Women ’s knowledge, awareness and prevention of cervical cancer and infection from HPV in Greece

ConclusionsThe majority of women in our sample know why they should do the Pap test; however, they need to be further informed with additional details about the diagnostic test. Although most of the women were aware about the importance of testing, one third of them were not regularly tested for cervical cancer detection or had lacked knowledge about vaccination.Key messagesA high percentage of women is aware about the benefits of cervical cancer screening.However, information campaigns and establishment of national screening programs are required to facilitate the access to such programs for all women.
Source: The European Journal of Public Health - Category: General Medicine Source Type: research

Related Links:

This study examined 65 female Burmese refugees who were candidates for HPV vaccinations and 106 female Burmese refugees who could have received Pap smear screenings between 2010 and 2020. Of the 65 patients aged 11 –26, 49.2% initiated the HPV vaccine series and 30.8% completed the series. In patients aged 13–17, 86.4% initiated the vaccine series and 54.6% completed the series. Of the 106 patients over 18 years of age, 32.1% had a Pap smear within the last 3 years. The need to improve HPV vaccine and Pa p smear rates in refugee populations is clear. While focusing on the designated refugee exam may h...
Source: Journal of Community Health - Category: International Medicine & Public Health Source Type: research
Prim Care. 2021 Dec;48(4):583-595. doi: 10.1016/j.pop.2021.07.008. Epub 2021 Oct 8.ABSTRACTDeclining cervical cancer rates in the United States highlights the value of prevention and early detection of premalignant cervical disease afforded by the human papillomavirus vaccine and Pap smear. The availability of in-office loop electrosurgical excision procedure affords clinicians with a cost-effective and preferred tool for the excision of high-grade lesions of the cervix with minimal risk for severe adverse outcomes. The most recent American Society for Colposcopy and Cervical Pathology guidelines recommend a risk-based app...
Source: Primary Care - Category: Primary Care Authors: Source Type: research
Declining cervical cancer rates in the United States highlights the value of prevention and early detection of premalignant cervical disease afforded by the human papillomavirus vaccine and Pap smear. The availability of in-office loop electrosurgical excision procedure affords clinicians with a cost-effective and preferred tool for the excision of high-grade lesions of the cervix with minimal risk for severe adverse outcomes. The most recent American Society for Colposcopy and Cervical Pathology guidelines recommend a risk-based approach for the detection, treatment, and surveillance of cervical disease and specifically f...
Source: Primary Care: Clinics in Office Practice - Category: Primary Care Authors: Source Type: research
The incidence of cervical cancer has slowly declined in the United States for the past 20 years (1). With human papillomavirus vaccination and Papanicolaou smear screening, this trend will hopefully continue, but profound disparities in access to and utilization of both of these preventive measures remain. For Black women in the United States, cervical cancer is the tenth leading cause of cancer death. Many of these women are young. According to the US Cancer Statistics Working Group, over 3,200 new cases of cervical cancer were diagnosed in women under 40 years old in 2017 (2).
Source: Fertility and Sterility - Category: Reproduction Medicine Authors: Tags: Reflections Source Type: research
CONCLUSION: The lack of an effective screening program for cervical cancer increases the likelihood of a late diagnosis and higher rates of complications and mortality. Public health programs should focus on cancer screening, screening, and reporting HPV infections, and supporting HPV vaccination activities.PMID:33632914 | DOI:10.15537/smj.2021.42.3.20200603
Source: Saudi Medical Journal - Category: Middle East Health Authors: Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Cervical Cancer | Education | General Medicine | Greece Health | International Medicine & Public Health | OBGYN | Papanicolaou (Pap) Smear | Study | Universities & Medical Training | Vaccines | Women